RNA sequencing reveals a unique fusion of the lysine (K)-specific methyltransferase 2A and smooth muscle myosin heavy chain 11 in myelodysplastic syndrome and acute myeloid leukemia.
作者信息
Sanders Mathijs A, Kavelaars François G, Zeilemaker Annelieke, Al Hinai Adil S A, Abbas Saman, Beverloo H Berna, van Lom Kirsten, Valk Peter J M
机构信息
Department of Hematology and Clinical Genetics, Erasmus University Medical Center, Rotterdam, the Netherlands.
Department of Hematology and Clinical Genetics, Erasmus University Medical Center, Rotterdam, the Netherlands
出版信息
Haematologica. 2015 Jan;100(1):e1-3. doi: 10.3324/haematol.2014.110775.
Abstract
摘要
相似文献
1
RNA sequencing reveals a unique fusion of the lysine (K)-specific methyltransferase 2A and smooth muscle myosin heavy chain 11 in myelodysplastic syndrome and acute myeloid leukemia.
Haematologica. 2015 Jan;100(1):e1-3. doi: 10.3324/haematol.2014.110775.
2
The Application of Targeted RNA Sequencing for KMT2A-Partial Tandem Duplication Identification and Integrated Analysis of Molecular Characterization in Acute Myeloid Leukemia.
J Mol Diagn. 2021 Nov;23(11):1478-1490. doi: 10.1016/j.jmoldx.2021.07.019. Epub 2021 Aug 10.
3
Cryptic t(6;11) KMT2A rearrangement in a pediatric acute myeloid leukemia patient detected by next-generation sequencing and dual-fusion FISH analysis.
Pediatr Blood Cancer. 2022 Mar;69(3):e29428. doi: 10.1002/pbc.29428. Epub 2021 Nov 12.
4
Novel variant form of t(11;22)(q23;q13)/MLL-EP300 fusion transcript in the evolution of an acute myeloid leukemia with myelodysplasia-related changes.
Leuk Res. 2011 Mar;35(3):e18-20. doi: 10.1016/j.leukres.2010.09.024. Epub 2010 Oct 25.
5
Whole transcriptome sequencing reveals a KMT2A-USP2 fusion in infant acute myeloid leukemia.
Genes Chromosomes Cancer. 2019 Sep;58(9):669-672. doi: 10.1002/gcc.22751. Epub 2019 Apr 8.
6
Homogeneously staining region (hsr) on chromosome 11 is highly specific for KMT2A amplification in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).
Cancer Genet. 2019 Oct;238:18-22. doi: 10.1016/j.cancergen.2019.07.001. Epub 2019 Jul 5.
7
Identification of a novel KMT2A-SEPT14 fusion in acute myeloid leukemia.
Leuk Lymphoma. 2018 Jan;59(1):265-267. doi: 10.1080/10428194.2017.1324163. Epub 2017 Jun 2.
8
Molecular characterization of KMT2A fusion partner genes in 13 cases of pediatric leukemia with complex or cryptic karyotypes.
Hematol Oncol. 2017 Dec;35(4):760-768. doi: 10.1002/hon.2299. Epub 2016 Jun 10.
9
A novel KMT2A-USO1 fusion gene-induced de novo secondary acute myeloid leukaemia in a patient initially diagnosed with acute promyelocytic leukaemia.
Br J Haematol. 2021 Jan;192(1):e32-e36. doi: 10.1111/bjh.17183. Epub 2020 Nov 20.
10
The pathogenesis of mixed-lineage leukemia.
Annu Rev Pathol. 2012;7:283-301. doi: 10.1146/annurev-pathol-011811-132434. Epub 2011 Oct 17.
引用本文的文献
1
Intermediate between Idiopathic Hypereosinophilia and Chronic Eosinophilic Leukemia: A Report of Two Hypereosinophilic Cases with Possible Novel Molecular Mutations.
Case Rep Hematol. 2021 Aug 31;2021:1142124. doi: 10.1155/2021/1142124. eCollection 2021.
2
Genomic and transcriptomic profiling of resistant CEM/ADR-5000 and sensitive CCRF-CEM leukaemia cells for unravelling the full complexity of multi-factorial multidrug resistance.
Sci Rep. 2016 Nov 8;6:36754. doi: 10.1038/srep36754.
本文引用的文献
1
Clinical and biological implications of driver mutations in myelodysplastic syndromes.
Blood. 2013 Nov 21;122(22):3616-27; quiz 3699. doi: 10.1182/blood-2013-08-518886. Epub 2013 Sep 12.
2
Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia.
N Engl J Med. 2013 May 30;368(22):2059-74. doi: 10.1056/NEJMoa1301689. Epub 2013 May 1.
3
TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions.
Genome Biol. 2013 Apr 25;14(4):R36. doi: 10.1186/gb-2013-14-4-r36.
4
Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group.
J Clin Oncol. 2013 Jan 1;31(1):95-103. doi: 10.1200/JCO.2011.41.5505. Epub 2012 Sep 24.
5
High BRE expression predicts favorable outcome in adult acute myeloid leukemia, in particular among MLL-AF9-positive patients.
Blood. 2011 Nov 17;118(20):5613-21. doi: 10.1182/blood-2011-06-359182. Epub 2011 Sep 21.
6
Molecular pathogenesis of core binding factor leukemia: current knowledge and future prospects.
Int J Hematol. 2011 Aug;94(2):126-133. doi: 10.1007/s12185-011-0858-z. Epub 2011 May 3.
7
Integrative genomics viewer.
Nat Biotechnol. 2011 Jan;29(1):24-6. doi: 10.1038/nbt.1754.
8
Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications.
J Clin Oncol. 2011 Feb 10;29(5):475-86. doi: 10.1200/JCO.2010.30.2554. Epub 2011 Jan 10.
9
New insights to the MLL recombinome of acute leukemias.
Leukemia. 2009 Aug;23(8):1490-9. doi: 10.1038/leu.2009.33. Epub 2009 Mar 5.
10
Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling.
Haematologica. 2009 Jan;94(1):131-4. doi: 10.3324/haematol.13299. Epub 2008 Oct 6.
Zotero 插件